The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Sanofi SA

NYSE: SNY
Last

(U.S.) $49.53

Today's change-0.06 -0.12%
Updated October 18 4:02 PM EDT. Delayed by at least 15 minutes.
 

Sanofi SA

NYSE: SNY
Last

(U.S.) $49.53

Today's change-0.06 -0.12%
Updated October 18 4:02 PM EDT. Delayed by at least 15 minutes.

Sanofi SA down (U.S.)$0.06

Sanofi SA closed lower Wednesday, dropping (U.S.)$0.06 or 0.12% to (U.S.)$49.53. Shares have lost 0.40% over the last five days, but sit 2.21% below their 52-week high. This security has outperformed the S&P 500 by 11.57% during the last year.

Key company metrics

  • Open(U.S.) $49.57
  • Previous close(U.S.) $49.59
  • High(U.S.) $49.75
  • Low(U.S.) $49.48
  • Bid / Ask(U.S.) $47.50 / (U.S.) $50.78
  • YTD % change+22.48%
  • Volume510,963
  • Average volume (10-day)1,362,910
  • Average volume (1-month)1,150,485
  • Average volume (3-month)1,230,985
  • 52-week range(U.S.) $36.81 to (U.S.) $50.65
  • Beta0.88
  • Trailing P/E22.73×
  • P/E 1 year forward14.94×
  • Forward PEG1.94×
  • Indicated annual dividend(U.S.) $1.64
  • Dividend yield3.31%
  • Trailing EPS(U.S.) $2.18
Updated October 18 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+13.20%

Based on its net profit margin of 13.20%, Sanofi SA is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.22%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue17,8308,89718,4729,295
Total other revenue--------
Total revenue17,8308,89718,4729,295
Gross profit12,1606,11212,7406,519
Total cost of revenue5,6702,7855,7322,776
Total operating expense14,7607,19615,0036,904
Selling / general / administrative5,0462,4784,8772,274
Research & development2,6671,3092,6581,221
Depreciation / amortization990503815403
Interest expense (income), net operating--------
Unusual expense (income)38911965684
Other operating expenses, total-22265146
Operating income3,0701,7013,4692,391
Interest income (expense), net non-operating-167---170--
Gain (loss) on sale of assets--------
Other--------
Income before tax2,9531,6383,2792,147
Income after tax2,3431,3022,4501,687
Income tax, total610336829460
Net income6,7385,7012,4641,674
Total adjustments to net income--------
Net income before extra. items2,3171,2742,4361,664
Minority interest-64-34-50-29
Equity in affiliates386366
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,3171,2742,4361,664
Inc. avail. to common incl. extra. items6,7385,7012,4641,674
Diluted net income6,7385,7012,4641,674
Dilution adjustment--------
Diluted weighted average shares1,2711,2621,2951,289
Diluted EPS excluding extraordinary itemsvalue per share1.821.011.881.29
Dividends per sharevalue per share0.000.002.960.00
Diluted normalized EPSvalue per share2.071.082.261.34